No benefit of adding docetaxel to ADT... - Prostate Cancer N...

Prostate Cancer Network

4,901 members3,038 posts

No benefit of adding docetaxel to ADT+RT in treating localized high-risk or pelvic lymph node only (N1) newly-diagnosed patients

Tall_Allen profile image
5 Replies

I updated this with the most recent STAMPEDE trial of adding docetaxel to ADT in what they call "high-risk" patients.

prostatecancer.news/2016/08...

Written by
Tall_Allen profile image
Tall_Allen
To view profiles and participate in discussions please or .
Read more about...
5 Replies
rosatt1 profile image
rosatt1

Thanks Tall_Allen for supplying up to date data.

Gabby643 profile image
Gabby643

Thanks T A

PGDuan profile image
PGDuan

Thanks for the update on this Tall__Allen. Very timely as many of us face treatment decisions in this situation space. Definitely an area to keep watching for continued updates.

garyjp9 profile image
garyjp9

Thank you, TA. I agree with the others. Very timely and relevant.

Ficus238 profile image
Ficus238

Thanks, Tall_Allen! Your experience/insight is why I’m here.

My PSMA PET just confirmed T0 N1 M0. 22 months after a perfect HIFU. PSA was non-detect at 3 months rising steady to 3.6 last week. (Pre HIFU: 4+3 Hopkins; Decipher “low risk”)

Based on Dr. Scholz’s “high indigo” I was preparing for Lupron + Zytiga + Taxotere for max efficacy. Haven’t seen RO/MO yet.

Your posting this study is reassuring and certainly has reduced my apprehension as to what’s to come next! Thank you!

You may also like...

Adding ADT to external beam radiation only benefits unfavorable risk patients

intermediate risk\\" patients are sometimes overtreated by doctors who give them adjuvant ADT. This...

FDA approves Erleada for metastatic hormone-sensitive prostate cancer

Joining Zytiga, and docetaxel. Probably Xtandi too very soon. https://pcnrv.blogspot.com/2019/05/two

Early side effects of docetaxel

regarding the early side effects of docetaxel. Mt partner started docetaxel on Monday (having 6...